Join experts Silvia Morbelli and Alexander Drzezga as they explore the evolving role of PET imaging in the diagnosis and management of Alzheimer’s disease from a European perspective. They examine the latest advancements in amyloid and tau PET imaging, including their clinical applications, limitations, and integration into diagnostic workflows. With a focus on current and emerging biomarker frameworks, such as the ATN and Core criteria, they also discuss the complementary roles of fluid and imaging biomarkers, implications for eligibility and monitoring of disease-modifying treatments, and the challenges of implementation in real-world European healthcare settings.
Select your language for captions by clicking on 
icon.
Subtitles are available in English, French, Spanish, Italian and German, Japanese and Simplified Chinese.
If you have any questions or comments on the topics discussed, please share these through our Imaging Exchange.
Title: Expert Exchange: The Europe Perspective
Release date: July 29, 2025
Expiration date: July 29, 2026
Estimated time to complete activity: 45 minutes
This program is intended for Imaging physicians, including Nuclear Medicine Physicians, Radiologists, Neuroradiologists, Radiology Physician Assistants, Imaging Residents. It is also suitable for Neurologists.
Following completion of this independent educational program, you will be able to:
Prof Silvia Morbelli
Full Professor of Nuclear Medicine, Department of Medical Sciences
University of Turin, Italy
Disclosures
Silvia Morbelli has received speaker honoraria from Eli-Lilly, Life Molecular Imaging, Novartis and GE Healthcare.
Prof Alexander Drzezga
Chair of the Department of Nuclear Medicine
University Hospital of Cologne, Germany
Disclosures
Alexander Drzezga has received grant funding and research support from Siemens Healthineers, Sofie, Novartis/AAA, Life Molecular Imaging, and Deutsche Forschungsgesellschaft; and honoraria or consulting fees from GE Healthcare, Biogen, Japan Radiological Society, Novartis, Lilly Deutschland, Peer View Institute for Medical Education Inc., Bayer Vital GmbH, European Research Council, Invicro, and International Atomic Energy Agency.
He holds Stocks, shares or equity in Siemens Healthineers and Lantheus Holding. In addition he has applied for patent for 2-Alkoxy-6-[18F]Fluoronicotinoyl substituted Lys-C(O)-Glu derivatives as efficient probes for imaging of PSMA expressing tissues (Patent No.: EP3765097A1). He is Associate Editor for The Journal of Nuclear Medicine, Nuklearmedizin/NuclearMedicine, and Nuklearmedizinische Hirnbildgebung in “Angewandte Nuklearmedizin”.
Credits available
Completing one Expert Exchange activity will earn you 0.5 AMA PRA Category 1 Credit(s)™. You can earn a total of 1.5 credits for all three activities.
In support of improving patient care, this activity has been planned and implemented by Postgraduate Institute for Medicine and Springer Healthcare IME. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
As part of the planning committee Rebecca Cox and Jules Morgan have no interests to disclose. The PIM staff has no financial relationships to disclose. All relevant financial relationships have been mitigated.
